Generate an explanation for the given claim using the provided supporting material from the paragraph. Please consider the following points while generating an output. 1) The claim will always have supporting proof in the paragraph, and the paragraph will have a clear point of view supporting the claim. 2) There can be instances where direct correlation to the claim is not available. Make use of the sentences in the paragraph to provide a corresponding output supporting the claim. 3) The explanation should be at least one and at most twelve sentences long.

Q: Paragraph: Made by Bayer AG and Onyx Pharmaceuticals Inc, Nexavar is  approved in the United States for kidney and liver cancer. Eight out of the first nine patients who took the drug saw  improvements in their ability to exercise, and six out of nine  had significant improvement in their right ventricular ejection  fraction, which measures the heart’s ability to pump blood to  the lungs. Four patients had decreased pressure in their pulmonary  artery, which supplies blood to the lungs. “What patients are telling us is they are able to do more  in their daily lives,” said Dr. Mardi Gomberg-Maitland of the  University of Chicago, who presented her findings at a meeting  of the American Thoracic Society in Toronto. The original  research on the drug was done at the University. She said the surprising thing is that the drug worked so  quickly. Patients saw benefits in only four months. The study is the first human trial to examine the  sorafenib, or Nexavar, in pulmonary hypertension, a disease in  which blood vessels feeding the lungs narrow, forcing the heart  to work harder. Like cancer, pulmonary hypertension is a disease marked by  abnormal cell growth, which narrows the arteries feeding the  lungs, reducing blood flow and taxing the heart. Sorafenib  appears to interfere with this process. The trial enrolled patients with stable disease who  continued to take their primary medications, which included a  continuous infusion of a drug called prostacyclin and Pfizer  Inc’s Viagra or sildenafil. Both relax blood vessels that feed  the lungs. Gomberg-Maitland said this therapy typically slows  progression of the disease, but does not reverse it. They added sorafenib for 16 weeks, but at a lower dose than  cancer patients use. Most patients in the trial increased their exercise  capacity, as measured by time on a treadmill or a six-minute  walk test. They saw an average 8 percent improvement in their  right ventricular ejection fraction, a measure of the heart’s  pumping power. Side effects included mild hair loss and skin reactions. The study was designed to last only 16 weeks, but all of  the patients continue to take the drug, some now for more than  a year. “What is exciting about this is all of the patients feel  better and nobody wants to come off the medication,”  Gomberg-Maitland said in a telephone interview. The study was intended to test the safety and dosing of the  drug. It was funded by The Doris Duke Foundation and the  University of Chicago. The researchers now plan to study the drug in 40 to 60  patients at different research centers. Claim: Nexavar helped in pulmonary hypertension study.

A: The cancer drug Nexavar is showed  promise in a small study of people with pulmonary hypertension,  a debilitating condition marked by high blood pressure in the  arteries that supply the lungs, U.S. researchers said on  Monday.
****
Q: Paragraph: "Emily's List is stoking the abortion debate in Colorado's 6th Congressional District race with a fundraising email saying Republican incumbent Mike Coffman ""co-sponsored a bill to redefine rape."" Emily's List -- a political organization that supports the election of Democratic women who support abortion rights -- has endorsed Coffman's opponent, state Sen. Morgan Carroll, an Aurora Democrat. Its mailer focused on reproductive rights, abortion and Roe v. Wade. In the email, titled ""2016 goal: A Congress that fights for women and families,"" Emily's List said, ""We wish Congress was less like this"" -- citing Mike Coffman's co-sponsorship of the 2011 bill -- ""and more like this … Morgan Carroll sponsored a bill to make emergency contraception available to sexual assault survivors."" We wanted to check the accuracy of Emily's List's characterization of Coffman's role in the legislation. Coffman did co-sponsor the No Taxpayer Funding for Abortions Act, which attempted to redefine a ban on federal funding for abortions to exempt ""forcible rape"" -- and not rape in broader terms. Critics said the ""forcible rape"" language could rule out other forms of sexual assault that are considered rape, including statutory rape, attacks where women are drugged or threatened, and date rapes. Facing a backlash from women's groups, Republicans amended the bill in committee to remove the word ""forcible"" and make the exemption for ""rape."" Coffman wasn't on this committee and didn't vote on the removal. ""The bill was amended in committee, and Congressman Coffman supported the amended bill on the floor,"" a Coffman campaign spokesman later said. Congressional records show that Coffman voted for the amended bill in a floor vote, which passed the House but not the Senate. In recent years, Coffman has tempered his position on abortion in one of the country's most competitive ""swing"" districts, which is nearly evenly divided among Democrats, Republicans and independents. In 2012, he said, ""I am against all abortions, except when it is necessary to protect the life of the mother."" But a year later, Coffman said that while he supported a House bill to limit late-term abortions, ""I strongly support the exceptions for rape, incest, and protecting the life of the mother that have been included in this legislation."" Coffman's Democratic opponent, Morgan Carroll, had blunt criticism of his co-sponsoring the 2011 bill's original ""forcible rape"" language. ""Rape is about the lack of consent -- not the degree of force -- and this definition takes us backwards,"" Carroll told Denver7. ""I unequivocally support a woman's right to make her own decisions about her own body, including her health care,"" she said. Coffman's spokeswoman complained that political opponents have repeatedly raised the 2011 bill and ""will twist the facts any way they can in an attempt to mischaracterize and demonize Rep. Coffman."" Our ruling Emily’s List said that Coffman ""co-sponsored a bill to redefine rape."" The record shows Coffman did co-sponsor the bill to redefine a ban on federal funding for abortions to exempt ""forcible rape."" Yet he later voted on the floor for an amended version that had removed the ""forcible"" modifier from the bill. Given the totality of his actions on the legislation, we're rating this claim . Correction: This story has been corrected to note that Coffman did not serve on the committee that removed the word ""forcible"" from the bill." Claim: "As part of legislative fights over abortion rights, ""Mike Coffman co-sponsored a bill to redefine rape."

A: "Emily’s List said that Coffman ""co-sponsored a bill to redefine rape."" The record shows Coffman did co-sponsor the bill to redefine a ban on federal funding for abortions to exempt ""forcible rape."" Yet he later voted on the floor for an amended version that had removed the ""forcible"" modifier from the bill. Given the totality of his actions on the legislation. Correction: This story has been corrected to note that Coffman did not serve on the committee that removed the word ""forcible"" from the bill."
****
Q: Paragraph: A passenger waits for a delayed flight at Heathrow airport's terminal four in London August 12, 2006. REUTERS/Toby Melville  The findings show that bariatric surgery, an increasingly  popular operation, benefits patients’ health and saves money,  according to Pierre-Yves Cremieux of the economic consulting  firm Analysis Group and the University of Quebec at Montreal,  who led the study. Bariatric surgery alters the digestive system’s anatomy,  reducing the volume of food that can be eaten and digested. The  most common form is gastric bypass, which makes the stomach  smaller and permits food to bypass part of the small intestine. Some insurers have been reluctant to cover this surgery. “It demonstrates the fact that this is not cosmetic  surgery,” Cremieux said in a telephone interview. “The reason why you get your money back when you cover  bariatric surgery is because the patients who were morbidly  obese before and had high rates of diabetes and hypertension no  longer do. They don’t go to the doctor as much as they used to,  and they don’t go to the emergency room as much as they used  to. Why? Because they are healthier,” Cremieux added. How quickly an insurer recovered the costs of paying for  bariatric surgery depended on the type performed, Cremieux  reported in the American Journal of Managed Care. Insurers fully recovered the expense of covering minimally  invasive bariatric surgery, which on average cost $17,000,  within about two years, the study showed. They fully recovered the expense of more common bariatric  procedures such as traditional gastric bypass surgery, which on  average cost $26,000, within about four years. After surgery, the obese patients lost weight and incurred  lower costs associated with prescription drugs, doctor visits  and hospital services as they became healthier and less  burdened by chronic disease, the researchers said. The researchers based the findings on insurance claims  filed by 3,651 morbidly obese bariatric surgery patients and  insurance claims filed by an equal number of morbidly obese  people who did not have weight-loss surgery. It spanned six months of pre-surgical evaluation and care,  the operation and up to five years of post-surgical care. Those  who did not have surgery also were tracked for five years. The average age of the surgical patients was 44 and most  were women. They began the study with obesity-related ailments  like high blood pressure, diabetes and sleep apnea. Previous research has found that obese people who have  weight-loss surgery are less likely to die from heart disease,  diabetes and cancer than obese people who do not have such  surgery. An estimated 205,000 people had bariatric surgery in  the United States last year. The study was funded by Johnson & Johnson’s Ethicon  Endo-Surgery division, which makes instruments for bariatric  surgery. Claim: Insurers recoup obesity surgery cost in 2-4 years.

A:
Insurers recoup the costs of  weight-loss surgery within two to four years as obese patients  become healthier and have fewer medical problems, researchers  said on Wednesday.
****